BONE DISEASE IN MULTIPLE MYELOMA-Reference-Cited by-同舟云学术

BONE DISEASE IN MULTIPLE MYELOMA

Published:1998-12 Issue:4 Volume:103 Page:902-910
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Croucher Peter I.,Apperley Jane F.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.1998.01082.x/fullpdf

Reference91 articles.

1. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP);Abildgaard;British Journal of Haematology,1997

2. Assessment of bone involvement in patients with multiple myeloma using bone densitometry;Abildgaard;European Journal of Haematology,1996

3. Cloning of a novel osteoclast stimulatory factor (OSF) expressed by ARH-77 cells and bone marrow cells from myeloma patients in vivo. (Abstract);Alsina;Blood,1995

4. Response patterns of purified myeloma cells to hematopoietic growth factors;Anderson;Blood,1989

5. In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates;Aparicio;Leukemia,1998

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adhesion molecules in multiple myeloma oncogenesis and targeted therapy;International Journal of Hematologic Oncology;2022-06

2. Newly Diagnosed Multiple Myeloma Patients with Skeletal-Related Events and Abnormal MRI Pattern Have Poor Survival Outcomes: A Prospective Study on 370 Patients;Journal of Clinical Medicine;2022-05-30

3. Chimeric Antigen Receptor T Cell Therapy: A Cutting-Edge Therapy for Multiple Myeloma;Biomedical Translational Research;2022

4. The Effects of Vitamin D Level on Bone Lesions and Prognostic Factors in Multiple Myeloma;Meandros Medical and Dental Journal;2021-08-01

5. The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR);Clinical Lymphoma Myeloma and Leukemia;2021-06